46.46.Z - Wholesale trade of pharmaceutical and medical products
32.50.Z - Production of medical devices, instruments, and products, including dental products
46.18.Z - Activity of agents involved in wholesale trade of other specified goods
46.90.Z - Non-specialized wholesale trade
47.74.Z - Retail sale of medical and orthopedic products
47.78.Z - Retail sale of other new products
47.99.Z - Retail trade
72.19.Z - Scientific research and development activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,5 | -0,2 | 0,3 | 257,6 |
EBITDA | -0,4 | -0,1 | 0,4 | 374,1 |
Short time liabilities | 2,3 | 1,9 | 1,5 | -22,2 |
Equity capital | -1,4 | -1,6 | -1,3 | 21,4 |
Operating profit (EBIT) | -0,4 | -0,1 | 0,4 | 374,1 |
Assets | 3,6 | 2,7 | 2,6 | -2,9 |
Net profit (loss) | -0,5 | -0,2 | 0,3 | 257,6 |
Cash | 0,1 | 0,2 | 0,1 | -49 |
Net income from sale | 1,5 | 2,2 | 2,5 | 12,4 |
Liabilities and provisions for liabilities | 5 | 4,3 | 3,9 | -9,9 |
Working assets | 3,6 | 2,7 | 2,6 | -2,9 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 32,6 | 13,6 | -27,3 | -40,9 |
Equity capital to total assets | -39,1 | -60,3 | -48,7 | 11,6 |
Gross profit margin | -29,8 | -10,1 | 14,1 | 24,2 |
EBITDA Margin | -28,4 | -5,9 | 14,5 | 20,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 549 | 318 | 220 | -98 |
Current financial liquidity indicator | 1.3128896951675415 | 1.4083194732666016 | 1.7591925859451294 | 0,4 |
Net dept to EBITDA | -5.027805805206299 | -17.07720184326172 | 6.475357532501221 | 23,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane